HKEX: 0241 - Alibaba Health Information Technology Limited

Yield per half year: +5.64%
Sector: Healthcare

Alibaba Health Information Technology Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
51.04 35.42 44.11% -7379.01 -100.69%
P/S 1.67 7.59 -78.01%
P/BV 2.87 3.68 -22.23%
P/FCF 62.49 55.3 13%
Ev/Ebitda 37.61 2.91 1193.23%
Ev/S 1.29 23.72 -94.57%
Ev/FCF 30.29 63.78 -52.51%
E/P 0.0123 0.0326 -62.31%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
3.43 -11.9 -128.79% 0.139 +2 365.61%
ROE 5.34 5.19 2.92%
ROA 3.92 3.47 13.01%
ROIC 0 0 0%
ROS 3.27 -11.49 -128.45%
ROCE 5.48 6.04 -9.24%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.0962 0.7755 -87.59% -0.613 -115.69%
Nеt Debt/Ebitda -11.08 0.0127 -87115.6%
Debt/Ratio 0.0042 0.1229 -96.6%
Debt/Equity 0.0057 0.776 -99.27%
Debt/Net Income 0.1008 1.76 -94.26%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 5.7 -100% 0 0%
Number of years of dividend growth 0 1.13 -100%
DSI 0 0.5838 -100%
Average dividend growth 0 3.2 -100%
Average percentage for 5 years 0 4.95 -100%
Average percentage for payments 89.11 23.96 271.92%
Difference from average difference in sector -5.7

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
181.67 28.69 533.22%
Growth impulse Ebitda in 5 years -200121.6 -40.52 493783.51%
Growth impulse Net Income in 5 years -13514.82 94.84 -14350.13%
Growth impulse FCF in 5 years 101.72 91.41 11.28%
Growth impulse EPS in 5 years -96561.54 -118.14 81634.84%
IP Score
4.44/10

Similar companies

JD Health International Inc.

Sino Biopharmaceutical Limited

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co. Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription